av/grifols--big.svg

NASDAQ:GRFS

Grifols, S.A.

  • Stock

USD

Last Close

8.50

01/05 20:00

Market Cap

5.87B

Beta: 0.43

Volume Today

2.20K

Avg: 963.98K

PE Ratio

29.17

PFCF: -

    Description

    Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chron...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.3-0.2-0.10.10.20.30.42016-11-082018-11-052020-11-052022-09-302024-05-14

    Revenue (Estimate*)

    500M1B1.50B2B2.50B3B2016-11-082018-11-052020-11-052022-09-302024-05-14

    *Estimate based on analyst consensus